Table 1.
Demographics and self-reported cannabis smoking characteristics for 11 chronic frequent cannabis smokers.
| Participanta | Sex | Age, yrs | BMI kg/m2 | Joints/dayb, n | Smoked in past 30 d | Age 1st smoked, yrs |
|---|---|---|---|---|---|---|
| A | M | 47 | 19.4 | 2.1 | 30 | 13 |
| B | M | 36 | 28.5 | 5.6 | 30 | 17 |
| C | M | 29 | 30.2 | 4.7 | 30 | 9 |
| E | F | 31 | 36.0 | 5.0 | 30 | 18 |
| H | M | 30 | 21.0 | 5.9 | 28 | 14 |
| I | M | 52 | 26.1 | 2.3 | 29 | 14 |
| J | M | 39 | 48.2 | 3.4 | 28 | 13 |
| K | M | 37 | 27.7 | 2.0 | 29 | 16 |
| M | M | 30 | 32.4 | 2.9 | 29 | 14 |
| N | M | 25 | 22.0 | 3.0 | 30 | 14 |
| P | M | 30 | 23.1 | 3.5 | 29 | 16 |
|
| ||||||
| Mean | 35.1 | 28.6 | 3.7 | 29.3 | 14.4 | |
| SD | 8.3 | 8.2 | 1.4 | 0.8 | 2.4 | |
a
All participants received four doses of dronabinol: 0 (placebo), 30 (10 mg tid), 60 mg/day (20 mg tid), or 120 mg/day (40 mg tid) in counterbalanced order during four 5-day medication sessions
b
Mean is calculated based on a self-reported daily use over the last 30 days